Explore Watchlists Pricing

SANTEN PHARMACEUTICAL CO.,LTD. (4536) Income statement

Market cap

¥685.5B

P/E ratio

17.1x

Santen Pharmaceutical develops and sells eye care medicines and medical devices worldwide, specializing in ophthalmology products for both prescription and over-the-counter markets.

Summary Financials Dividends History Ownership Workforce

Income statement Balance sheet Cash flow Other

	2012/03	2013/03	2014/03	2015/03	2016/03	2017/03	2018/03	2019/03	2020/03	2021/03	2022/03	2023/03	2024/03	2025/03	2026/03
Revenue	114,416	119,066	148,663	161,881	195,291	199,096	224,942	234,026	241,555	249,605	266,257	279,037	301,965	300,004	291,624
Revenue growth (%)	-
Cost of revenue	-	-	-	56,373	72,829	74,966	70,205	75,222	78,476	81,391	87,402	87,415	92,062	96,587	86,760
Gross profit	-	-	-	105,458	122,463	124,130	101,667	100,986	104,134	104,721	103,425	109,174	103,176	91,513	85,020
Gross margin (%)	-	-	-
Operating margin (%)	-	-	-
Operating expenses	-	-	-	55,430	65,085	64,284	70,369	68,137	69,700	81,108	82,037	84,376	75,164	68,105	64,503
Operating income	-	-	-	33,188	30,713	31,311	31,298	45,098	33,535	12,917	35,886	-3,090	38,541	46,880	47,797
Income before tax	27,780	25,602	30,361	35,863	79,470	31,822	39,261	43,117	32,091	12,418	35,616	-5,799	29,874	47,481	47,442
Pretax margin (%)	24.3	21.5	20.4	22.2	40.7	16	17.5	18.4	13.3	5	13.4	-2.1	9.9	15.8	16.3
Provision for income taxes	-	-	-	11,221	23,401	5,617	7,564	9,946	10,014	5,663	7,783	9,501	7,123	7,333	6,566
Effective tax rate (%)	-	-	-
Net income	17,160	16,520	19,718	24,032	53,373	23,061	35,247	31,954	23,618	6,830	27,218	-14,948	26,642	36,256	37,369
Earnings per share	196.96	195.81	47.78	58.18	128.99	56.2	86.73	78.67	59.16	17.09	68.07	-38.6	72.59	103.98	114.04
Diluted EPS	196.76	195.51	41.33	54.41	123.79	60.7	62.36	68.76	68.46	54.33	43.53	-38.6	50.74	50.89	48.08
Dividend payout ratio (%)	-	-	-	-	-	-	-	-
Dividend per share	-	-	-	-	-	-	-	-	27	28	32	32	33	36	38